FINWIRES · TerminalLIVE
FINWIRES

BioMarin Pharmaceutical Q1 Revenue Beat Backed by Voxzogo Strength, Diversified Portfolio, Wedbush Says

By

-- BioMarin Pharmaceutical (BMRN) reported a Q1 beat on revenue, driven by Voxzogo and continued portfolio diversification amid emerging competition, Wedbush Securities said in a note Tuesday.

Voxzogo and total revenue came in at $220 million and $766 million, compared with the consensus of $216 million and $757 million, respectively. The decline from Q4 was mainly seasonal, and the company expects a stronger H2, due to recent acquisitions of Galafold and Pombiliti/Opfolda, the firm said.

The firm said the company has kept its Voxzogo guidance unchanged at $975 million to $1.025 billion, and despite rising competition, BioMarin plans to focus on execution to maintain its lead in achondroplasia using "robust" safety and efficacy data and broad early-treatment use.

"Recall management announced in January a goal of achieving sustained double-digit long-term total revenue compound annual growth rate into the 2030s, and we believe that BioMarin Pharmaceutical remains on track to deliver," the firm said.

Wedbush Securities has an outperform rating and $94 price target on BioMarin Pharmaceutical.

Price: $54.05, Change: $-1.42, Percent Change: -2.55%

Related Articles

Sectors

Update: Gold Rises As Treasury Yields Ease

(Updates prices.)Gold traded higher midafternoon on Tuesday, rising off a five-week low as treasury yields weakened.Gold for June delivery was last seen up US$35.60 to US$4,568.90 per ounce.The price of the metal has remained mostly rangebound for a month as the war on Iran has prompted some safe-haven demand for the metal, even as the higher oil prices that followed the start of the war on Iran is hiking inflation. The threat of higher interest rates because of rising prices is pushing up bond yields, bearish for the metal since it pays no interest."The benchmark US 10-year yield rose some seven basis points on the day Monday, closing just below 4.44% and therefore at the highest daily close since last July as traders eye the big round 4.50% level.," Saxo Bank wrote.However yields moderated early on Tuesday, with the U.S. two-year note last seen paying 3.944%, down 1.8 basis points, while the yield on the 10-year note was down 2.2 points to 4.42%. The dollar was higher, with the ICE dollar index last seen up 0.04 points to 98.42.

$GCM6$GLD
Research

Research Alert: CFRA Maintains Buy Opinion On Shares Of First Quantum Minerals

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target price by CAD5 to CAD40, on an EV/EBITDA of 8.0x our 2027 EBITDA estimate, a discount to FM's three-year average forward EV/EBITDA of 10.6x but close to peers, with an average of 8.3x. We lower our 2026 EPS estimate by $0.33 to $0.53 and 2027 by $0.22 to $1.95. FM faces near-term cost pressures from Middle East tensions, with fuel representing 15% of total costs and potential upward pressure of $0.25/lb on C1 guidance (fuel +$0.20, Kwacha +$0.10, partially offset by gold -$0.05). However, the company's fundamentals remain strong with authorization to process Cobre Panama stockpiles (30-40kt copper expected in 2026), Kansanshi S3 operating 25% above design, and record nickel production at Enterprise. FM strengthened its balance sheet with a $1.5B 10-year bond at 6.375% and extended maturities to 2036. The Taca Taca project (291kt/year copper over first 10 years, 19.3% IRR) provides significant long-term growth optionality once the balance sheet is positioned to support development.

$FM
Australia

Market Chatter: Apple to Let Users Choose Third-Party AI Models With iOS 27

Apple (AAPL) will let users select from multiple third-party artificial intelligence models for tasks across its iOS 27 software, Bloomberg reported Tuesday, citing people with knowledge of the matter.Users will be able to select rival AI models for tasks like generating and editing text and images when the change becomes available for iOS 27, iPadOS 27 and macOS 27, slated for this fall, the report said, citing the people.Apple didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $283.22, Change: $+6.34, Percent Change: +2.29%

$AAPL